Observational studyRMD open2024

Risk of severe infection associated with immunoglobulin deficiency under rituximab therapy in immune-mediated inflammatory disease.

Claire Rempenault et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.